Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARA NYSE:FEO CVE:MNO NASDAQ:REG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARAAmerican Renal Associates$11.52$11.50$5.57▼$11.98$397.94M1.11106,940 shs9,831 shsFEOFirst Trust/abrdn Emerging Opportunity Fund$9.58$9.40$8.35▼$14.16N/AN/A27,706 shs150,253 shsMNOMeridian Mining UK SocietasC$1.03+9.6%C$1.03C$0.37▼C$1.34C$152.09MN/A220,803 shs247,282 shsREGRegency Centers$72.05-0.5%$71.37$63.44▼$78.18$13.10B1.091.10 million shs618,130 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARAAmerican Renal Associates0.00%0.00%0.00%0.00%0.00%FEOFirst Trust/abrdn Emerging Opportunity Fund0.00%0.00%0.00%0.00%0.00%MNOMeridian Mining UK Societas0.00%0.00%0.00%0.00%0.00%REGRegency Centers-0.94%+0.08%+0.65%+1.94%-2.75%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARAAmerican Renal Associates$11.52$11.50$5.57▼$11.98$397.94M1.11106,940 shs9,831 shsFEOFirst Trust/abrdn Emerging Opportunity Fund$9.58$9.40$8.35▼$14.16N/AN/A27,706 shs150,253 shsMNOMeridian Mining UK SocietasC$1.03+9.6%C$1.03C$0.37▼C$1.34C$152.09MN/A220,803 shs247,282 shsREGRegency Centers$72.05-0.5%$71.37$63.44▼$78.18$13.10B1.091.10 million shs618,130 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARAAmerican Renal Associates0.00%0.00%0.00%0.00%0.00%FEOFirst Trust/abrdn Emerging Opportunity Fund0.00%0.00%0.00%0.00%0.00%MNOMeridian Mining UK Societas0.00%0.00%0.00%0.00%0.00%REGRegency Centers-0.94%+0.08%+0.65%+1.94%-2.75%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARAAmerican Renal Associates 0.00N/AN/AN/AFEOFirst Trust/abrdn Emerging Opportunity Fund 0.00N/AN/AN/AMNOMeridian Mining UK Societas 3.00BuyC$1.5045.63% UpsideREGRegency Centers 2.67Moderate Buy$78.679.18% UpsideCurrent Analyst Ratings BreakdownLatest FEO, MNO, ARA, and REG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/9/2025REGRegency CentersLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$76.008/28/2025REGRegency CentersScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$75.00 ➝ $76.008/27/2025REGRegency CentersBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$77.00 ➝ $79.008/27/2025REGRegency CentersWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$79.00 ➝ $81.008/20/2025REGRegency CentersMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$74.00 ➝ $77.008/15/2025REGRegency CentersTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$79.00 ➝ $81.007/30/2025REGRegency CentersRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$78.00 ➝ $80.007/30/2025REGRegency CentersEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetIn-Line$79.00 ➝ $80.007/17/2025REGRegency CentersMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$79.00 ➝ $74.007/2/2025REGRegency CentersBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageEqual Weight$77.00(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARAAmerican Renal Associates$822.52M0.48$1.69 per share6.80$2.59 per share4.45FEOFirst Trust/abrdn Emerging Opportunity FundN/AN/AN/AN/AN/AN/AMNOMeridian Mining UK Societas-C$4.33K-35,148.07C$0.02 per share57.22C($0.04) per share-24.52REGRegency Centers$1.49B8.75$4.27 per share16.89$36.78 per share1.96Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARAAmerican Renal Associates-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/AFEOFirst Trust/abrdn Emerging Opportunity FundN/AN/A0.00∞N/AN/AN/AN/AN/AMNOMeridian Mining UK SocietasN/A-C$0.31N/A∞N/AN/AN/AN/AN/AREGRegency Centers$400.39M$2.1433.7315.433.1627.00%6.05%3.22%10/27/2025 (Estimated)Latest FEO, MNO, ARA, and REG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q2 2025REGRegency Centers$1.12$1.16+$0.04$1.16$366.35 million$369.85 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARAAmerican Renal AssociatesN/AN/AN/AN/AN/AFEOFirst Trust/abrdn Emerging Opportunity Fund$1.4014.61%N/AN/AN/AMNOMeridian Mining UK SocietasN/AN/AN/AN/AN/AREGRegency Centers$2.823.91%N/A131.78%5 YearsLatest FEO, MNO, ARA, and REG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/5/2025REGRegency Centersquarterly$0.70503.82%9/11/20259/11/202510/2/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARAAmerican Renal Associates7.541.051.02FEOFirst Trust/abrdn Emerging Opportunity FundN/AN/AN/AMNOMeridian Mining UK SocietasN/A1.121.06REGRegency Centers0.721.131.13Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARAAmerican Renal Associates78.42%FEOFirst Trust/abrdn Emerging Opportunity FundN/AMNOMeridian Mining UK SocietasN/AREGRegency Centers96.07%Insider OwnershipCompanyInsider OwnershipARAAmerican Renal Associates9.50%FEOFirst Trust/abrdn Emerging Opportunity FundN/AMNOMeridian Mining UK SocietasN/AREGRegency Centers1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARAAmerican Renal Associates4,97734.54 millionN/AOptionableFEOFirst Trust/abrdn Emerging Opportunity FundN/AN/AN/ANot OptionableMNOMeridian Mining UK SocietasN/A147.66 millionN/ANot OptionableREGRegency Centers440181.55 million179.74 millionOptionableFEO, MNO, ARA, and REG HeadlinesRecent News About These CompaniesWhat's that steel structure being built at 43rd Avenue and Oslo Road next to Publix?September 10 at 3:54 AM | msn.comLADENBURG THALM/SH SH Initiates Coverage on Regency Centers (NASDAQ:REG)September 10 at 2:46 AM | americanbankingnews.comRegency Centers initiated with a Neutral at LadenburgSeptember 9 at 10:53 PM | msn.comWhere Regency Centers Stands With AnalystsSeptember 9 at 10:53 PM | benzinga.comLadenburg Thalmann Initiates Coverage of Regency Centers Corporation - Preferred Stock (REGCP) with Neutral RecommendationSeptember 9 at 10:53 PM | msn.comRegency Centers Corporation (REG) Presents At BofA Securities 2025 Global Real Estate Conference TranscriptSeptember 9 at 6:01 PM | seekingalpha.comAdelante Capital Management LLC Buys 18,444 Shares of Regency Centers Corporation $REGSeptember 9 at 7:53 AM | marketbeat.comUniplan Investment Counsel Inc. Cuts Stake in Regency Centers Corporation $REGSeptember 9 at 5:59 AM | marketbeat.comAlyeska Investment Group L.P. Buys New Shares in Regency Centers Corporation $REGSeptember 9 at 4:25 AM | marketbeat.comAmundi Buys 351,709 Shares of Regency Centers Corporation $REGSeptember 9 at 4:25 AM | marketbeat.comAdage Capital Partners GP L.L.C. Sells 98,600 Shares of Regency Centers Corporation $REGSeptember 9 at 4:15 AM | marketbeat.comRegency Centers Corporation (NASDAQ:REG) Receives Consensus Rating of "Moderate Buy" from AnalystsSeptember 9 at 2:53 AM | marketbeat.comVident Advisory LLC Sells 8,462 Shares of Regency Centers Corporation $REGSeptember 6, 2025 | marketbeat.comNomura Holdings Inc. Has $3 Million Position in Regency Centers Corporation $REGSeptember 4, 2025 | marketbeat.comPublix to anchor Regency Centers’ new Village at Seven Pines development in JacksonvilleSeptember 4, 2025 | msn.com5 Reasons to Add Regency Centers Stock to Your Portfolio NowSeptember 3, 2025 | zacks.comFJ Capital Management LLC Takes $717,000 Position in Regency Centers Corporation $REGSeptember 3, 2025 | marketbeat.comRafferty Asset Management LLC Sells 3,700 Shares of Regency Centers Corporation $REGSeptember 3, 2025 | marketbeat.comRegency Centers to Present at the BofA Securities 2025 Global Real Estate ConferenceSeptember 2, 2025 | globenewswire.comRaymond James Financial Inc. Has $13.61 Million Stock Holdings in Regency Centers Corporation $REGSeptember 1, 2025 | marketbeat.comInstitutional Backing Fuels Regency Centers' Retail Real Estate AscentAugust 31, 2025 | aktiencheck.deANew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 2025IPO Market Stays Hot With These 2 Debuting StocksBy Dan Schmidt | August 11, 2025Is Paramount Skydance a Buy Post-Merger, Short Squeeze?By Leo Miller | August 24, 2025Here's What Separates Oklo From the Rest of the Nuclear Startups By Jordan Chussler | September 5, 20253 Stocks Poised to Gain from a September Rate CutBy Chris Markoch | September 4, 2025FEO, MNO, ARA, and REG Company DescriptionsAmerican Renal Associates NYSE:ARAAmerican Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.First Trust/abrdn Emerging Opportunity Fund NYSE:FEOFirst Trust-abrdn Emerging Opportunity Fund is a closed-ended balanced mutual fund launched and managed by First Trust Advisors L.P. It is co-managed by Aberdeen Asset Management Inc. The fund invests in public equity and fixed income markets of global emerging countries. It seeks to invest in the stocks of companies operating across the diversified sectors. For its fixed income component, the fund invests in government debt securities, corporate bonds, non investment-grade securities, asset-backed securities, credit-linked notes, and credit default swaps. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the Barclays Capital Global Emerging Markets Index, FTSE All World Emerging Market Index, and a blended index composed of JPMorgan Emerging Markets Bond Index - Global Diversified (32.5%); JPMorgan Government Bond Index - Emerging Markets (32.5%); MSCI Global Emerging Markets Index (35.0%). First Trust-abrdn Emerging Opportunity Fund was formed on August 28, 2006 and is domiciled in the United States.Meridian Mining UK Societas CVE:MNOC$1.03 +0.09 (+9.57%) As of 04/1/2022Meridian Mining UK Societas, together with its subsidiaries, engages in the acquisition, exploration, and development of mineral properties in Brazil. The company explores for manganese, gold, copper, and tin deposits. It holds interest in the Espigão polymetallic project and the Ariquemes tin project located in Rondônia. The company also has an option to acquire a 100% interest in the Cabaçal copper-gold project located in the state of Mato Grosso; and the Mirante da Serra project located in Rondônia. The company was formerly known as Meridian Mining S.E. Meridian Mining UK Societas was founded in 2013 and is headquartered in London, the United Kingdom.Regency Centers NASDAQ:REG$72.05 -0.34 (-0.47%) As of 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Regency Centers is a preeminent national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. Operating as a fully integrated real estate company, Regency Centers is a qualified real estate investment trust (REIT) that is self-administered, self-managed, and an S&P 500 Index member. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle Has Spoken: AI Changes Everything Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Alphabet Stock’s Weakness Was Wall Street’s Opportunity Should You Buy Figma Stock After Its 55% Post-IPO Drop? Ulta Beauty Stock: Strong Growth, Short-Term Volatility Ahead Joby's Stock Is Quiet, But a Storm of Catalysts Is Brewing Beyond DIY: Home Depot's Conquest of the Professional Market Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
